Page last updated: 2024-11-01

norfloxacin and Leukemia P388

norfloxacin has been researched along with Leukemia P388 in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, YL1
Cai, SH1
Wang, L1
Kitaichi, K1
Tatsumi, Y1
Nadai, M1
Yoshizumi, H1
Takagi, K2
Hasegawa, T1
Castelli, M1
Barbieri, ML1
Bertolini, A1
Bossa, R1
Galatulas, I1

Other Studies

2 other studies available for norfloxacin and Leukemia P388

ArticleYear
Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin.
    Clinical and experimental pharmacology & physiology, 2002, Volume: 29, Issue:3

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B

2002
Bactericidal and antineoplastic effect of combination of norfloxacin and adriamycin.
    Chemotherapy, 1987, Volume: 33, Issue:5

    Topics: Animals; Bacteria; Bacterial Infections; Carcinoma, Ehrlich Tumor; Doxorubicin; Drug Interactions; D

1987